By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sigma-Tau Pharmaceuticals 

800 South Frederick Avenue, Suite 300

Gaithersburg  Maryland  20877  U.S.A.
Phone: 800-447-0169 Fax:




HEMOSYSTEM® SA  exclusive worldwide license for L-carnitine patents related to the blood transfusion field

SciClone Pharmaceuticals, Inc.  European Union partner for the development and commercialization of ZADAXIN in Europe.

Company News
Sigma-Tau Pharmaceuticals Signs Exclusive Agreement With Crosscare Limited For U.S. Marketing And Distribution License Of Colief® Infant Drops For The Treatment Of Colic-Associated Crying 8/11/2014 7:30:14 AM
Jazz Pharmaceuticals plc (JAZZ) Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals 8/6/2014 7:47:56 AM
Walgreens Named Exclusive Specialty Pharmacy Provider For Sigma-Tau Pharmaceuticals’s, Prescription Drugs: Adagen®, Cystaran Adagen® and Matulane Adagen® 7/31/2014 8:43:22 AM
Jazz Pharmaceuticals plc (JAZZ) Wagers Up To $250 Million On Rare Disease Drug From Sigma-Tau Pharmaceuticals 7/2/2014 6:45:51 AM
Sigma-Tau Pharmaceuticals Announces First Patient Dosed In Phase 1/2 Clinical Trial Of STP206 For Prevention Of Necrotizing Enterocolitis In Very Low Birth Weight Premature Infants 2/4/2014 9:14:00 AM
Sigma-Tau PharmaSource, Inc. and Aradigm Corporation (ARDM) Sign Manufacturing Agreement for the Clinical and Commercial Supply of Pulmaquin 9/16/2013 10:00:36 AM
Sigma-Tau Pharmaceuticals Receives Innovation Award From the National Organization for Rare Disorders for Its Advancements in Rare Diseases 5/16/2013 9:12:27 AM
Sigma-Tau Pharmaceuticals Launches CYSTARAN™ for the Treatment of Corneal Cystine Crystal Accumulation in Patients With Cystinosis 5/1/2013 11:44:49 AM
Dave Lemus Promoted to CEO of Sigma-Tau Pharmaceuticals 4/29/2013 8:52:57 AM
Sigma-Tau Pharmaceuticals Announces Appointment of New Vice President of Commercial Operations 10/29/2012 7:10:42 AM